Sorafenib
Pharmacology, Toxicology and Pharmaceutical Science
100%
Oxide
Pharmacology, Toxicology and Pharmaceutical Science
59%
CYP3A4
Pharmacology, Toxicology and Pharmaceutical Science
59%
Polycyclic Aromatic Hydrocarbon
Pharmacology, Toxicology and Pharmaceutical Science
56%
Liver Cell Carcinoma
Pharmacology, Toxicology and Pharmaceutical Science
54%
Lenvatinib
Pharmacology, Toxicology and Pharmaceutical Science
50%
Malonaldehyde
Pharmacology, Toxicology and Pharmaceutical Science
50%
Low Density Lipoprotein
Pharmacology, Toxicology and Pharmaceutical Science
50%
Takahashi, M. ,
Okada, K. ,
Ouch, R. ,
Konno, T. ,
Usui, K. ,
Suzuki, H. ,
Satoh, M. ,
Kogure, T. ,
Satoh, K. ,
Watanabe, Y. ,
Nakamura, H. &
Murai, Y. ,
2021 12月 5 ,
In: Die Pharmazie. 76 ,
12 ,
p. 594-601 8 p. 研究成果: Article › 査読
Lenvatinib
100%
Hypoxia
76%
Cells
76%
Fibronectin
61%
Hepatocellular Carcinoma
38%
Iboshi, H. ,
Yamaguchi, H. ,
Suzuki, H. ,
Kikuchi, M. ,
Tanaka, M. ,
Takasaki, S. ,
Takahashi, A. ,
Maekawa, M. ,
Shimada, M. ,
Matsuda, Y. ,
Okada, Y. &
Mano, N. ,
2017 ,
In: Therapeutic drug monitoring. 39 ,
6 ,
p. 648-653 6 p. 研究成果: Article › 査読
Mycophenolate Mofetil
100%
Glucuronide
46%
Dried Blood Spot
46%
Sample
30%
Liquid Chromatography
23%
Abe, K. ,
Suzuki, H. ,
Maekawa, M. ,
Shimada, M. ,
Yamaguchi, H. &
Mano, N. ,
2017 5月 1 ,
In: Clinica Chimica Acta. 468 ,
p. 187-194 8 p. 研究成果: Article › 査読
Acylcarnitine
100%
Carnitine
66%
Biological Marker
33%
Drug
33%
Cefditoren
33%
Nakagawa, N. ,
Murai, Y. ,
Yoshida, M. ,
Suzuki, H. &
Mano, N. ,
2015 8月 25 ,
In: Journal of Pharmaceutical Health Care and Sciences. 1 ,
1 , 23.
研究成果: Article › 査読
Enalapril Maleate
100%
Drug
33%
Tenidap
33%
Shimada, M. ,
Okawa, H. ,
Kondo, Y. ,
Maejima, T. ,
Kataoka, Y. ,
Hisamichi, K. ,
Maekawa, M. ,
Matsuura, M. ,
Jin, Y. ,
Mori, M. ,
Suzuki, H. ,
Shimosegawa, T. &
Mano, N. ,
2015 10月 16 ,
In: Tohoku Journal of Experimental Medicine. 237 ,
3 ,
p. 173-182 10 p. 研究成果: Article › 査読
Sorafenib
100%
Oxide
83%
Adverse Event
33%
Liver Cell Carcinoma
25%
Pharmacokinetics
8%